Egyptian Rheumatology and Rehabilitation
Scope & Guideline
Fostering collaboration in the realm of rheumatic diseases.
Introduction
Aims and Scopes
- Rheumatic Disease Research:
The journal covers a broad spectrum of rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and psoriatic arthritis, focusing on their etiology, pathophysiology, and management. - Clinical and Experimental Studies:
It publishes clinical trials, case reports, and experimental studies that explore novel treatment modalities, biomarkers, and disease mechanisms, providing evidence-based insights into patient care. - Rehabilitation Techniques and Outcomes:
The journal emphasizes the importance of rehabilitation in the management of rheumatic diseases, exploring various therapeutic interventions, exercise programs, and their effects on patient outcomes. - Cultural and Epidemiological Context:
Research that addresses the unique epidemiological factors and healthcare challenges faced in Egypt and the broader region is highlighted, promoting localized clinical guidelines and treatment strategies. - Interdisciplinary Collaboration:
The journal encourages collaboration among rheumatologists, rehabilitation specialists, and researchers to enhance the understanding and management of musculoskeletal disorders.
Trending and Emerging
- Biomarkers for Disease Activity:
There is an increased focus on identifying and validating biomarkers for disease activity and treatment response in various rheumatic conditions, underscoring the importance of personalized medicine. - Multimodal Treatment Approaches:
The trend towards integrating pharmacological and non-pharmacological interventions, including exercise and rehabilitation techniques, is growing, reflecting a holistic approach to patient care. - Impact of Comorbidities on Rheumatic Diseases:
Emerging research is increasingly addressing the impact of comorbid conditions, such as diabetes and cardiovascular diseases, on rheumatic diseases, highlighting the need for comprehensive management strategies. - Technological Innovations in Diagnosis and Treatment:
The use of advanced technologies such as ultrasound, MRI, and telemedicine in the diagnosis and management of rheumatic diseases is gaining traction, enhancing clinical outcomes and patient engagement. - Psychosocial Aspects of Rheumatic Diseases:
There is a rising interest in exploring the psychosocial aspects of living with rheumatic diseases, including mental health, quality of life, and patient-reported outcomes, which are essential for holistic patient management.
Declining or Waning
- Traditional Pharmacological Approaches:
There is a noticeable decline in studies focused solely on conventional pharmacological treatments for rheumatic diseases, such as methotrexate and corticosteroids, as newer biologics and targeted therapies gain traction. - General Awareness and Education Studies:
Research articles that primarily focus on general public awareness or educational programs about rheumatic diseases have diminished, indicating a shift towards more in-depth clinical and experimental research. - Longitudinal Studies on Established Treatments:
The frequency of longitudinal studies evaluating long-established treatments and their long-term effects has decreased, possibly replaced by studies on newer therapeutic interventions and their immediate outcomes. - Case Reports of Rare Conditions:
While case reports remain valuable, there seems to be a waning interest in rare or atypical presentations of rheumatic conditions, with a preference for more prevalent diseases and standard treatment protocols. - Traditional Rehabilitation Techniques:
Traditional rehabilitation methods are being overshadowed by innovative and technology-driven rehabilitation approaches, leading to fewer publications on conventional rehabilitation practices.
Similar Journals
International Journal of Rheumatic Diseases
Advancing understanding in rheumatology.The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.
Pediatric Rheumatology
Connecting global experts to elevate pediatric health research.Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.
RHEUMATOLOGY
Innovating Care Through Groundbreaking Pharmacology InsightsRHEUMATOLOGY, published by Oxford University Press, is a leading journal in the fields of Pharmacology and Rheumatology, recognized for its significant contribution to advancing the understanding and treatment of rheumatic diseases. With an impressive impact factor and ranking within the top quartiles for both medical pharmacology and rheumatology, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals. The journal spans an extensive publication history, with contributions from 1952 to 1995 and from 1998 to 2024, reflecting its enduring commitment to disseminating high-quality research. The Open Access option allows for broader dissemination of knowledge, enhancing the visibility of groundbreaking studies. Positioned in the United Kingdom, RHEUMATOLOGY not only offers valuable insights into the latest therapeutic advancements and clinical guidelines but also fosters collaboration across disciplines, ensuring that practitioners stay at the forefront of innovation in the management of rheumatic conditions.
Current Rheumatology Reviews
Pioneering insights for modern rheumatology.Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.
ARP Rheumatology
Empowering Global Discourse in RheumatologyARP Rheumatology is a pioneering open-access journal dedicated to the field of rheumatology, published by the esteemed Sociedade Portuguesa Reumatologia. Since its inception in 2022, this journal has aimed to bridge the gap between research and clinical practice, providing a platform for the dissemination of high-quality research, case studies, and reviews that advance the understanding and management of rheumatic diseases. Although currently classified in the Q4 category of rheumatology journals with a Scopus rank of 56/73, our commitment to academic excellence and engagement with our readership is unwavering. Located in Portugal, ARP Rheumatology supports a global community of researchers, professionals, and students by maintaining rigorous peer-review standards and promoting innovative scientific discourse. With accessible content and a focus on the latest advancements in the field, ARP Rheumatology is poised to make a significant impact on the future of rheumatology research and practice.
JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION
Enhancing knowledge for effective musculoskeletal solutions.JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, published by IOS PRESS in the Netherlands, serves as a vital resource for researchers and practitioners in the fields of orthopedics, physical therapy, and rehabilitation. Since its inception in 1992, this peer-reviewed journal has been committed to advancing knowledge in the prevention and treatment of musculoskeletal disorders, showcasing high-quality research and clinical studies. With a commendable category ranking of Q2 in Physical Therapy and Rehabilitation, as well as Q3 in Orthopedics and Sports Medicine, the journal has established itself as an influential platform in the academic community, holding a Scopus rank that underscores its relevance and impact. While currently not an open-access publication, it offers insightful contributions that are pivotal for improving clinical practices and patient outcomes. The journal's ongoing commitment to excellence is reflected in its focus on the latest methodologies and therapeutic interventions, making it an essential reading for those dedicated to pushing the boundaries of musculoskeletal health.
Reumatismo
Unveiling breakthroughs in rheumatic disease management.Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.
Reumatologia
Exploring innovative methodologies in rheumatic diseases.Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.
Orthopadie
Shaping the future of orthopedics through collaboration and discovery.Orthopadie is a pivotal journal in the field of orthopedics and sports medicine, published by SPRINGER. With its ISSN 2731-7145 and E-ISSN 2731-7153, this journal serves as a key resource for researchers, professionals, and students looking to stay updated with the latest advancements in orthopedic practices and sports-related injuries. Based in Germany, it reflects a commitment to fostering rigorous academic dialogue and innovative research from 2022 to 2024. The journal has achieved a respectable Q3 category ranking in Orthopedics and Sports Medicine for 2023, positioning it within the competitive landscape of its field, ranking #214 out of 321 in *Scopus* for its subject area. While currently not offering open access options, the journal remains dedicated to disseminating vital findings that enhance understanding and treatment within the orthopedic community. With a growing impact within the scientific community, Orthopadie is poised to become an essential platform for pioneering research and knowledge in orthopedics.
JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY
Transforming Physical Therapy with High-Quality InvestigationsJOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY (JOSPT), published by J O S P T, is a premier peer-reviewed journal that has made significant contributions to the fields of orthopaedic and sports physical therapy since its inception in 1979. With an impressive impact factor and consistently ranking in the Q1 category for Medicine, Physical Therapy, Sports Therapy and Rehabilitation, and Sports Science in 2023, this journal stands at the forefront of evidence-based practice and innovative research. JOSPT aims to disseminate high-quality investigations, systematic reviews, and groundbreaking clinical practices that enhance both rehabilitation techniques and athletic performance. Notably, it ranks #12 among 247 in the Scopus database for Health Professions related to Physical Therapy, reflecting its influence and recognition within the academic community. As a comprehensive resource for researchers, clinicians, and students alike, JOSPT facilitates access to the latest developments in physical therapy, thereby promoting improved patient outcomes and advancing the science of rehabilitation.